Skip to content
Open access

T-pGNN4DTI: Towards better drug-target interactions prediction using Global Self-attentive Pooled Graph Convolutional Networks and protein pre-training Models

Jul 2026 · PLoS ONE · Vol 21, pp. e0352250 - e0352250 · 0 citations · 53 references
Medicine

TL;DR

A DTI prediction method based on the global self-attentive pooled graph neural network and protein pretraining model, called T-pGNN4DTI, which uses a global self-attention pooled graph neural network to learn more meaningful features of the drug molecule.

Abstract

Identification of drug-target interactions (DTI) is an important and challenging task in drug discovery and development. Traditional methods generally require biological experiments, which are costly and time-consuming. Machine learning-based methods can rapidly predict DTI using only computer algorithmic models, allowing researchers to validate only the most promising interactions through biochemical experiments. This holds promise for effectively addressing the current challenges of lengthy development cycles and high costs in new drug development. However, it is difficult for the existing DTI prediction methods to learn complete and effective feature information from the compound and protein. Therefore, this work proposes a DTI prediction method based on the global self-attentive pooled graph neural network and protein pretraining model, called T-pGNN4DTI. On the one hand, T-pGNN4DTI uses a global self-attention pooled graph neural network to learn more meaningful features of the drug molecule by paying more attention to the information features of certain important atomic nodes of the molecular structure and ignoring some weakly relevant node information features. On the other hand, T-pGNN4DTI uses a pre-trained Transformer-based model to capture the semantic relationships of contexts in long sequences of proteins, which can learn more complete feature information. The results of comparing experiments on three benchmark datasets show that the performance of the proposed T-pGNN4DTI model is better than that of the existing DTI prediction methods, effectively improving the DTI prediction. It provides a new way of thinking to help solve the DTI-related problems.

Read PDF

Similar papers

Conference Open access 2026

Prediction of Drug Target Interactions Based on Artificial Intelligence

This review systematically summarizes the latest developments in heterogeneous graph neural networks, protein language models, and generative artificial intelligence, pointing out the problems currently being addressed in research such as data sparsity and cold start as well as the manifestations of general machine learning challenges.

Qi-Zhong Yang · 0 citations
Aug 2026

IHLO-DTI: Drug-Target Interaction Prediction Based on Improved Hypergraph Neural Network and Laplacian Matrix Optimization

IHLO-DTI, a novel prediction model based on an improved hypergraph neural network and Laplacian matrix optimization, can effectively capture high-order many-to-many interactions between drugs and targets, improving prediction accuracy and robustness.

Guolongwei Dai, Tao Luo, Dandan Li et al. · 0 citations
Open access Jul 2026

Robust Prediction of Drug Interactions using Chemical Descriptors.

T-DDI pairs confidence-stratified predictions with LIME-based feature-level explanations and a web application for screening, supporting more reliable drug safety monitoring, and outperforming all evaluated baselines within the architectures and datasets considered here.

Q. Kha, Duc-Quang-Anh Nguyen, Phi Pham Van Hoang et al. · 0 citations
Conference Jul 2026

A Drug-Target Affinity Prediction Model Based on Bayesian Meta-Learning and Uncertainty Fusion

In the early stages of drug discovery, predicting drug-target affinity is a crucial task. Due to the vast scale of genomic and chemical spaces, traditional biological methods are time-consuming, labor-intensive, and resource-demanding. As a result, machine learning-based computational methods have emerged to narrow down the pool of drug candidates. However, machine learning approaches still face several challenges in practical applications, particularly the scarcity of labeled samples and poor model generalization capability. To address these issues, this paper proposes a novel drug-target affinity prediction model, termed MetaBayes-DTA, based on an uncertainty-aware meta-learning framework. The model integrates the few-shot rapid adaptation capability of meta-learning with an uncertainty quantification mechanism to enhance prediction accuracy and reliability. MetaBayes-DTA is evaluated on two benchmark datasets, DAVIS and KIBA. Experimental results demonstrate that the proposed model outperforms existing methods.

Naihan Shi, Yanpeng Zhao, Wanying Li et al. · 0 citations
Open access Jul 2026

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

This study applies MPS2IT-DTI (Molecule and Protein Sequence to Image Transformer for Drug-Target Interaction), a deep learning framework that represents molecular and protein sequences as images as images using k-mer frequency encoding, enabling convolutional neural networks to capture spatial compositional patterns associated with biochemical interactions.

Jackson G. de Souza, Marcelo A. C. Fernandes, Raquel de Melo Barbosa · 0 citations

ProphDR: An Interpretable Deep Learning Model for Predicting Cancer Drug Response via Multi-Omics and Cross-Attention Mechanisms

ProphDR is an interpretable deep learning framework that integrates multiomics data and drug structural information using a hierarchical attention mechanism, and generates biologically interpretable attention maps that highlight key pharmacophores and resistance-related genes consistent with established mechanisms in NSCLC and BRCA.

Yundian Zeng, Qing Ye, Jike Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.